Oxymatrine relieves high-fructose/fat-induced obesity via reprogramming the activity of lipid metabolism-related enhancer

Oxymatrine relieves high-fructose/fat-induced obesity via reprogramming the activity of lipid metabolism-related enhancer

IntroductionEmerging evidence demonstrates that the high-fructose and high-fat diet (HFHF) induced obesity and fatty liver disease has become one of the most common metabolic disorders worldwide. Therefore, innovative investigations on compounds targeting obesity and fatty liver diseases are urgentl...

Full description

Bibliographic Details
Main Authors: Luping Ren, Xuehua Liu, Xitong Huang, He Zhang, Wenjie Fei, Xian Yu, Zhijuan Hu, Yunfeng Zhen, Shuchun Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Endocrinology
Subjects:
obesity
oxymatrine
Smad3
enhancer
fatty liver disease
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1145575/full

Similar Items

Similar Items